South African global pharmaceutical giant Aspen Pharmacare has found itself caught in Trump tariff-related market volatility, ...

They're not just leaders of their industry. Their underlying businesses are also on the verge of enormous growth.

Aspen’s share price plummeted by 30% after it warned shareholders that its earnings could significantly decline due to a ...

The biopharmaceutical industry saw a strong start to 2025, despite ongoing uncertainty around the potential impact of US ...

WASHINGTON - Talks continue between the U.S. and China on tackling the fentanyl epidemic amid the bitter trade war between ...

Dr. Rietiker has considerable experience in the life sciences industry, including leadership positions in global pharmaceutical and medical device companies, and has overseen multiple major company ...

The European Union should allow drug prices to rise to U.S. levels in order to attract investment, the bosses of two European ...

CEOs from European drugmakers Sanofi and Novartis have inked a letter in The Financial Times urging the European Union to set ...